Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]. Fromm MF, Kim RB, Stein CM, Wilkinson GR, Roden DM (1999) Circulation 99: 552-7 Digoxin associates with mortality in ESRD. Chan KE, Lazarus JM, Hakim RM (2010) J Am Soc Nephrol 21: 1550-9 Identification of functionally variant MDR1 alleles among European Americans and African Americans. Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwarz UI, Taylor A, Xie HG, McKinsey J, Zhou S, Lan LB, Schuetz JD, Schuetz EG, Wilkinson GR (2001) Clin Pharmacol Ther 70: 189-99 "Inactive" excipients such as Cremophor can affect in vivo drug disposition. Wandel C, Kim RB, Stein CM (2003) Clin Pharmacol Ther 73: 394-6 Digoxin toxicity and ritonavir: a drug interaction mediated through p-glycoprotein? Phillips EJ, Rachlis AR, Ito S (2003) AIDS 17: 1577-8 A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE, Wheeler W, Soler-Soler J, Swedberg K (1997) Am Heart J 134: 44-54 Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin. Cover TL, Reddy LY, Blaser MJ (1993) Infect Immun 61: 1427-31 Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease. Califf RM, McKinnis RA, Burks J, Lee KL, Harrell FE, Behar VS, Pryor DB, Wagner GS, Rosati RA (1982) Am J Cardiol 50: 23-31 Pharmacologic correction of dominant-negative GH1 deficiency causing mutations. Poling JS, Phillips JA, Cogan JD, Hamid R (2011) Clin Transl Sci 4: 175-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.